Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum DiaMedica Therapeutics Inc DMAC

DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in... see more

Bullboard (NDAQ:DMAC)

View:
Comment by Pandoraon Jun 17, 2019 12:48pm

RE:RE:RE:RE:RE:RE:Reality FINALLY Sinks in

A little bit of price action but not much on volume this morning. Not sure what is causing it.
Comment by RockLobster1on Jun 17, 2019 10:44am

RE:RE:RE:RE:RE:Reality FINALLY Sinks in

yes that was a big raise so I am hopeful they can make some progress without raising money until some results are in. 
Comment by TrueNorth911on Jun 06, 2019 7:29pm

RE:RE:RE:RE:Reality FINALLY Sinks in

Thier latest quarterly report showed over $14MM in Cash/Securities. I believe they are supposed to get another $4-$5MM cash once their licensing deal gets approved in China?  So.. they are ...more  
Comment by RockLobster1on Jun 06, 2019 4:52pm

RE:RE:RE:Reality FINALLY Sinks in

On Dec 7 last year they sold 4m shares at $4 US... It killed the stock... the markets had been terrible going into December and they raised at a low price into a falling market. The 4 m shares was ...more  
Comment by TrueNorth911on Jun 04, 2019 9:47pm

RE:RE:Reality FINALLY Sinks in

That's the point. We all know they'll need to raise more $ at some point, as do all early stage pharma companies.  It's just that it should be on the back of positive results and a ...more  
Comment by Pandoraon Jun 03, 2019 11:09pm

RE:Reality FINALLY Sinks in

I'm sure it will rise significantly if & when it comes out with results. We're just in that all too familiar "wait" mode. So, so many!
Post by Roadster2on Jun 03, 2019 8:12pm

Reality FINALLY Sinks in

"As much as I'd like to see a $2 to $5 appeciation.... i just don't think it can, based on the fact that raising like $16M USA sank the stock 40%!..........damn." Read more at https: ...more  
Comment by Pandoraon Jun 03, 2019 5:11pm

RE:RE:RE:RE:Update and Results

Can we say we have a positive note -- DiaMedica Therapeutics (NASDAQ:DMAC) Richard D Pilnik (Director) Buy 19,000 shares @ $2.80 $53,200.00 5/31 ...more  
Comment by Winnipeg40on May 18, 2019 10:24am

RE:RE:RE:RE:Update and Results

20% from new US institutions, 10% in Canada, 5% from management and insiders and 15% from the Chinese partner (approximate numbers here ) if someone wanted to buy 250K shares in one day, the stock ...more  
Comment by Pandoraon May 17, 2019 4:16pm

RE:RE:RE:Update and Results

They could certainly use "hard and fast" particularly the 'fast'.   Bid = 0, ask = $3.68 Closed at $2.70  -- certainly was a well timed move to the Nasdaq. Divide $2 ...more  
Comment by Pugsrock2on May 16, 2019 10:10pm

RE:RE:RE:Update and Results

Hey Winnipeg. What percent of the float is held institutuonally?
Comment by Winnipeg40on May 16, 2019 8:32pm

RE:RE:Update and Results

Based on the conference call, Mgmt seems to feel that when they announce their CKD advisory team and get the licencing deal with Ahon....they will have strong interest. Clearly one analyst was made ...more  
Comment by Pandoraon May 14, 2019 3:03pm

RE:Update and Results

Seems like the conference call and the results did not generate a lot of trading interest although it did eventually take a bump up around 1 p.m. A long way to go yet though to get back where we ...more  
Post by Pandoraon May 13, 2019 5:52pm

Update and Results

MINNEAPOLIS, May 13, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for kidney diseases and ...more  
Comment by TheSkyIsFallingon May 08, 2019 7:05pm

RE:RE:RE:RE:RE:RE:RE:RE:Where's RodSter2????

I don't think it was that money was raised that dropped the share price... it was how it was raised! Huge discount, no news to follow, big FU to existing shareholders. Surprised it didn't drop ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities